ST. PAUL, Minn.--(BUSINESS WIRE)--EnteroMedics Inc. (NASDAQ: ETRM) announced today that Mark B. Knudson, Ph.D., Chief Executive Officer, is scheduled to present at the 28th Annual Canaccord Adams Global Growth Conference in Boston, MA on Tuesday, August 12th at 11:30 am ET. Dr. Knudson will provide an overview of the Company and an update on its VBLOCTM vagal blocking therapy development program.
